Packaging & Labelling Flashcards

1
Q

Packaging & leaflets

A

It is an offence for anyone other than the MA holder to:
- Sell (or offer to sell)
- Supply (or offer to supply)
A medicine (human) which:
- does not comply with the packaging legislation
- without a leaflet
Offenders:
- fine
- conviction
- imprisonment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Public law

A
  • Applies to everyone e.g criminal, constitutional, administrative law.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

By law

A
  • you have to supply a leaflet when dispensing meds
  • manufacturer has to fulfil certain requirements for the manufacturing packaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does the HMR legislation say?

A

All labelling of containers & packages must be:
- Legible, comprehensible & indelible
- provided in English
Package:
- enclosure for one or more containers
Container:
- inner receptacle which actually contains the medicine
- Could be a bottle or pack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Labelling Requirements MA Holders (1-5)
For the outer packaging

A
  1. Name (& brand name) of medicinal product (must also be in Braille)
  2. Strength & pharmaceutical form
  3. Whether intended for babies, children or adults (where appropriate)- if it is just for adults you don’t need to write anything
  4. Active substance common name
    (for up to 3 active substances)
  5. Qualitative & quantitative expression of the
    active substance (common name) per
    dosage unit or for a given volume or weight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Labelling Requirements MA Holders (6-11)
For the outer packaging

A
  1. Pharmaceutical form & contents by weight, volume or number of doses
  2. The method of administration
  3. Where appropriate, space for the prescribed dose to be indicated (i.e., POMs require space for a dispensing label)
  4. A warning that the product must be stored out of the reach & sight of children
  5. Any applicable special warnings
  6. Any applicable storage precautions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Labelling Requirements MA Holders (12-17)
For the outer packaging

A
  1. Expiry date (month and year)
  2. Manufacturer’s batch number (lot no.)
  3. Name & address of MA holder
  4. Marketing Authorisation number (Product licence no.= PL number)
  5. Legal category if P or POM and if not a POM, instructions for use
  6. Any special disposal precautions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Labelling Requirements
MA Holders (18)

A
    1. A list of ( for certain products)
      A) all excipients for injectable, topical or eye products
      B) in any other case, excipients with a recognised
      action or effect (i.e. anything active or colourings should be listed as s/ may be allergic to them, lactose allergy, peanut oil).
      Excipient:
  • “a constituent of a medicine other than the active
    substance, added in the formulation for a specific
    purpose… Most …are…inactive, some…have a
    known action … must be declared…” EMA, 2021
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Best Design Practice for Safety
MHRA Guidance for MA Holders

A
  • Packaging & labelling must be approved by
    MHRA (includes changes) before marketed (for patient safety)
  • Labelling can contribute to medication error
  • Critical information together (same field of view)
  • Full name on 3 non-opposing faces (at least)
  • Generic cephalosporins Tallman lettering = Certain letters are highlighted or in bold to make it clear as to what exactly you are picking. Highlights differences in the name & helps things stand out.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Best Design Practice for Safety
MHRA Guidance for MA Holders

A
  • manufacturers must express different strengths of the same drug in the same manner using the same units (e.g., 250mg, 500mg, 750mg, 1000mg and NOT 1g)
  • No trailing zeros (e.g., 2.5mg and NOT 2.50mg) as they may be misread
  • ‘micrograms’ is spelt out in full (not abbreviated) so that it isn’t misread
  • Positive administration instructions only = For INTRATHECAL use ONLY = Clearer & more easily processed
  • Consider colour to ensure accurate identification & selection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Con of similar designs

A
  • s/ manufacturers use the same design across all their products & in busy settings one may not be able to easily distinct which is which
  • errors can be made
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Labelling Requirements
MA Holders

A
  • Legislation allows symbols, diagrams, pictures or additional information:
  • In line with summary of product characteristics (SmPC) = Has to be in w/ the licensed use of that drug)
  • NOT promotional
  • Fewer requirements for blister packs & small containers= Have to have expiry date & batch number
  • Specific additional requirements for Traditional Herbal Remedies, homeopathic products & radiopharmaceuticals
  • Different requirements for ‘special’ medicines, ingredients, contract manufacture, assembly & clinical trials (Special meds = Meds made specifically for a patient aren’t licensed)
  • Additional requirements for paracetamol products
  • Additional requirements for codeine & dihydrocodeine products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Labelling Requirements
Paracetamol Products

A

The following words MUST appear on the package
- ‘Contains paracetamol’ unless already stated in product name
- ‘Do not take more medicine than the label tells you to. If you do not get better, talk to your doctor’ adjacent to dose directions
- If intended for over 12-year-olds ‘Do not take anything else containing paracetamol while taking this medicine. Talk to a doctor at once if you take too much of this medicine, even if you feel well’ (not e/o feels unwell)
- Either the leaflet or the packaging must include the explanation ‘This is because too much paracetamol can cause delayed, seriousliver damage’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does paracetamol have labelling requirements?

A
  • Paracetamol untreated can result in irreversible
    hepatotoxicity & death
  • Legislation change 1998
  • Pack size sales restrictions
  • From 100 tablets (pharmacy) & 24 tablets (non-
    pharmacy)
  • To 32 tablets (pharmacy) & 16 tablets (non-
    pharmacy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Labelling Requirements
Paracetamol Products

A

The following words MUST appear on the package
- If intended for under 12-year-olds ‘Do not give anything
else containing paracetamol while giving this
medicine. Talk to a doctor at once if your child takes
too much of this medicine, even if they seem well’ = The same warning just rephrased for the caregiver
- Either the leaflet or the packaging must include the
explanation ‘This is because too much paracetamol can
cause delayed, serious liver damage’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Labelling Requirements
Codeine & Dihydrocodeine Products

A

Over-the-counter (P & GSL) packs MUST
include the following warning on the front
- ‘Can cause addiction, (only take) for three days only’
- Max. pack size of 32 tablets

15
Q

Patient Information Leaflet Requirements

A
  • must be included unless all required information is on the packaging
  • Requirement also applies to products dispensed in accordance with a prescription
  • Publicly available by MHRA = MHRA approves them
  • In accordance with the SmPC= Summary of product characteristics
  • Patient education & safety
16
Q

Leaflet Requirements
MA Holders

A
  • Name of medicinal product
  • Strength & pharmaceutical form
  • Whether intended for babies, children or adults (where appropriate)
  • Active substance common name (for up to 3 active substances)
  • Drug pharmaco-therapeutic group or type of activity (lay language)= What type of drug is this
  • Therapeutic indications= What the drug is for
17
Q

Leaflet Requirements
MA Holders

A

A list of
− Contraindications (e.g., pregnancy, breastfeeding)= Who can not take the drug
− Precautions= Who needs to use it w/ caution
− Interactions (medicines and other substances)
− Special warnings (e.g., possible effects on the ability to drive & operate machinery) Drowsy
- Instructions for use (e.g., dose, route, frequency etc)
- Adverse reactions (i.e., ALL known side-effects in W/ most common first)

18
Q

Leaflet Requirements
MA Holders

A
  • Reference to expiry date, storage requirements, active ingredients & excipients, name & address of MA holder, name & address of manufacturer
  • Information on adverse event reporting = Side effects reporting
  • Date last revised
    Additional requirements for:
    − Paracetamol, codeine & dihydrocodeine products (warnings)
    − Radiopharmaceuticals
19
Q

Legal Requirements of Dispensing Labels (1-3)

A
  • Medicines dispensed in accordance with a prescription MUST be labelled
  • Outer package or container
    Label MUST include the following:
    1. Patient name
    2. Name & Address of supplier = e.g Supplying pharmacy
    3. Date supplied
20
Q

Legal Requirements of Dispensing Labels (4)

A

Label MUST include the following:
4. Pharmacist professional judgement is
allowed for the following (substitute for similar
alternative if prescription not appropriate)
- Product name (include quantity, product
name/form, strength where appropriate)
- Directions for use
- Precautions relating to product use
(e.g., ‘For external use only’ on a cream)
Optimise dispensing labels for patient safety

21
Q

Dispensing Labels
Good Practice & Guidance
These are not legal requirements but good practice

A
  • Keep out of reach & sight of children’
    ▪ Dispense & Check boxes for operator(s) initials=
    − Governance procedures
    − Dispense against prescription (operator 1)
    − Check labelled product against prescription (operator 2)
    ▪ Cautionary & Advisory Labels=
    − aka CALs, auxiliary labels
    − 30 CALs listed in the British National Formulary (BNF)
  • If you don’t include CAL s you must have a good reason as to why = For patient safety
22
Q

Dispensing Labels
Good Practice & Guidance

A
  • Patient full name (not just initials) & title
    (distinguishes between family members)
  • Good labelling practice for directions (see
    practical 03)= Directions for use
  • Outer package vs container (a container need
    not be labelled if it is in a package which is labelled BUT
    consider whether outer package will be discarded e.g.,
    inhalers, creams)